These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 236714)

  • 21. Pharmacodynamic observations on metronidazole therapy. Side effects in endocrine, metabolic and auto-immune disorders. 3. Anti-ischemic and anti-inflammatory action in peripheral vascular disorders.
    Taylor JA
    Proc West Pharmacol Soc; 1966; 9():37-9. PubMed ID: 4381145
    [No Abstract]   [Full Text] [Related]  

  • 22. Analysis of commercial samples of dimethyl sulfoxide.
    Reeves WP; Creswell M; Squires WG
    Med Sci Sports Exerc; 1989 Jun; 21(3):348-9. PubMed ID: 2733586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of dimethylsulfoxide (DMSO) in patients with lesions of the supportive-locomotor apparatus].
    Dubinskiĭ MB; Skager AA
    Ortop Travmatol Protez; 1970 Jan; 31(1):74-5. PubMed ID: 5441301
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment results with dimethyl sulfoxide in circumscribed scleroderma].
    Gärtner R; Flegel H
    Dermatol Wochenschr; 1968 Oct; 154(43):1015-22. PubMed ID: 5733089
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunosuppressive agents for therapy of autoimmune diseases of the skin and of psoriasis].
    Ruszczak Z
    Hautarzt; 1977 Mar; 28(3):125-31. PubMed ID: 15957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dimethyl sulfoxide in scleroderma.
    Ehrlich GE; Joseph R
    Pa Med; 1965 Dec; 68(12):51-3. PubMed ID: 5856390
    [No Abstract]   [Full Text] [Related]  

  • 27. A clinical trial with dimethyl sulfoxide in scleroderma.
    Tuffanelli DL
    Arch Dermatol; 1966 Jun; 93(6):724-5. PubMed ID: 5326715
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experience report on the use of DMSO in general practice].
    Kumpmann U
    Med Welt; 1968 Feb; 6():397-9. PubMed ID: 5713888
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experiences with long-term immunosuppressive therapy of connnective tissue diseases].
    Apostoloff E; Reitzig P; Jendrusch C; Apostoloff G
    Z Gesamte Inn Med; 1974 Jan; 29(1):26-30. PubMed ID: 4820047
    [No Abstract]   [Full Text] [Related]  

  • 30. The employment of dimethyl sulfoxide as an antiinflammatory agent and steroid-transporter in diversified clinical diseases.
    Steinberg A
    Ann N Y Acad Sci; 1967 Mar; 141(1):532-50. PubMed ID: 5232266
    [No Abstract]   [Full Text] [Related]  

  • 31. [CONTRIBUTION TO THE STUDY OF OSTEOARTICULAR MANIFESTATIONS OF SCLERODERMA, POLYMYOSITIS AND PERIARTERITIS NODOSA].
    FRENEAUX B
    Fr Med; 1963 May; 26():307-8. PubMed ID: 14060965
    [No Abstract]   [Full Text] [Related]  

  • 32. DIMETHYL SULFOXIDE IN MUSCULOSKELETAL DISORDERS.
    ROSENBAUM EE; HERSCHLER RJ; JACOB SW
    JAMA; 1965 Apr; 192():309-13. PubMed ID: 14271981
    [No Abstract]   [Full Text] [Related]  

  • 33. Experience with dimethyl sulfoxide.
    Marmor L; Walike B
    Calif Med; 1966 Jul; 105(1):28-30. PubMed ID: 5329861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental design of clinical trials testing the efficacy of 90% DMSO solution in injuries to the musculoskeletal system in the dog.
    Averkin E; Kilian J; O Brien T; Sickles J
    Vet Med Small Anim Clin; 1975 Feb; 70(2):177-9. PubMed ID: 1037766
    [No Abstract]   [Full Text] [Related]  

  • 35. [On therapeutic action of dimethyl-sulfoxide (RE 421) in sport traumas and in osteoarticular atlas diseases].
    Venerando A; Dal Monte A; Montanaro M
    Gazz Int Med Chir; 1965 Oct; 69(19):1605-16. PubMed ID: 5852189
    [No Abstract]   [Full Text] [Related]  

  • 36. Laboratory investigations in connective tissue disease.
    Solomon L
    Mod Trends Orthop; 1972; 5():172-95. PubMed ID: 4114353
    [No Abstract]   [Full Text] [Related]  

  • 37. [Indications and limits of long-term therapy with immunosuppressive (and cytostatic) agents in various chronic skin diseases].
    Schulze P
    Z Arztl Fortbild (Jena); 1977 Jun; 71(12):562-4. PubMed ID: 20701
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of dimethylsulfoxide in complex therapy of patients with systemic scleroderma].
    Balabanova RM; Aliab'eva AP; Akhnazarova VD; Oskilko TG; Alekberova ZS
    Ter Arkh; 1977; 49(11):99-103. PubMed ID: 605410
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experience in the therapeutic use of indocid in chronic joint diseases].
    Astapenko MG; Surovtseva VM; Chepoĭ VM; Pavlenko IM; Pikhlak EG; Baiatova KV
    Vopr Revm; 1970; 10(1):48-52. PubMed ID: 5427370
    [No Abstract]   [Full Text] [Related]  

  • 40. [Dimethyl sulfoxide and aspects of its use in dermatology].
    Rakhmanov VA; Ivanov OL; Potekaev NS; Azhgikhin IS; Konstantinov AV; Iashkul' MV
    Vestn Dermatol Venerol; 1967 Feb; 41(2):13-8. PubMed ID: 5620469
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.